Jeff Schaffnit: Global Voices in Hemophilia Care at the World Federation of Hemophilia World Congress
Jeff Schaffnit, General Manager and Head of Rare Blood Disorders at Sanofi, shared a post on LinkedIn:
“This week I had the privilege of joining the global hemophilia community at the World Federation of Hemophilia World Congress in Kuala Lampur, Malaysia.
The meeting was nothing short of inspiring—being in the room with clinicians, researchers, patient advocates and people living with hemophilia from around the world was a powerful reminder of why our work matters.
At Sanofi, we remain committed to advancing care for people with rare blood disorders, and moments like these continue to reinforce our team’s sense of urgency and purpose.
I’m grateful for the connections and conversations and look forward to what’s ahead.”
Stay updated with Hemostasis Today.
-
Sep 21, 2026, 12:15Kholoud Al Busaidi: Cold Agglutination and Its Impact on CBC and Blood Grouping Results
-
Sep 21, 2026, 11:03Shaurav Bhattacharyya: Honoring the 2026 Lasker Award Winners
-
Sep 21, 2026, 10:41Jamshid Ullah: Recognizing Blood Disorders Through Laboratory Findings
-
Sep 21, 2026, 10:18Mana Alshehri: A New Step Toward Hemophilia B Gene Therapy in Adolescents
-
Sep 21, 2026, 09:52Afreenish Tasadaq: Contributing to Awareness about Bleeding Disorders
-
Sep 21, 2026, 08:49Andrea Bridges: When Support Becomes a Commitment to Give Back
-
Sep 21, 2026, 08:21Managing Thrombotic Risk in Pregnancy
-
Sep 21, 2026, 04:06Allison Lewin: How Gender Shapes the Way We Receive Medical Care
-
Sep 21, 2026, 03:49Jessica Lee: Walking Together for a Stronger Bleeding Disorders Community